子宫肌瘤剔除术路径与生育力:一项前瞻性队列研究
基于美国八家临床中心的多中心前瞻性队列研究(COMPARE-UF),纳入1095例因症状性子宫肌瘤接受子宫肌瘤剔除术的育龄女性,比较经腹、宫腔镜与腹腔镜三种手术路径与妊娠及活产的关系,随访36个月。结果显示不同手术路径的妊娠或活产概率无显著差异。
要点
- 在1095例接受子宫肌瘤剔除术的女性中,随访36个月内202例报告妊娠、91例报告活产。
- 经宫腔镜与经腹腔镜子宫肌瘤剔除术相较于经腹途径,妊娠的调整OR分别为1.28(95%CI 0.76-2.14)和1.19(95%CI 0.76-1.85)。
- 在有妊娠意愿的女性中,经宫腔镜与经腹腔镜相较于经腹途径的妊娠调整OR分别为1.27(95%CI 0.72-2.23)和1.26(95%CI 0.77-2.04)。
核心结论
- 在术后观察36个月的女性中,子宫肌瘤剔除术路径与受孕或活产的概率无显著差异。
研究设计与样本
- 前瞻性队列研究,数据来自美国八家临床中心组成的多中心全国性注册研究COMPARE-UF。
- 研究对象为因症状性子宫肌瘤接受手术的育龄女性。
- 采用生命表法估算随访12、24、36个月时妊娠与活产的累积概率及95%CI(2015-2019年)。
- 采用基于12个月间隔的分析,以logistic回归估算OR及95%CI。
- 所有分析均使用倾向评分加权校正不同手术路径间的差异。
主要发现
- 1095例接受子宫肌瘤剔除术的女性中,经腹388例、宫腔镜273例、腹腔镜434例;随访36个月内202例报告妊娠、91例报告活产。
- 总体上及在有妊娠意愿的女性中,经腹、宫腔镜与腹腔镜三种路径的12个月妊娠或活产概率差异很小。
- 间隔分析中,相较于经腹子宫肌瘤剔除术,经宫腔镜者妊娠调整OR为1.28(95%CI 0.76-2.14),经腹腔镜者为1.19(95%CI 0.76-1.85)。
- 在有妊娠意愿的女性中,相较于经腹途径,经宫腔镜者妊娠调整OR为1.27(95%CI 0.72-2.23),经腹腔镜者为1.26(95%CI 0.77-2.04)。
- 活产的关联略强但精确度较低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess prospectively the association between the myomectomy route and fertility. DESIGN: Prospective cohort study. SETTING: The Comparing Treatments Options for Uterine Fibroids (COMPARE-UF) Study is a multisite national registry of eight clinic centers across the United States. PATIENT(S): Reproductive-aged women undergoing surgery for symptomatic uterine fibroids. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): We used life-table methods to estimate cumulative probabilities and 95% confidence intervals (CI) of pregnancy and live birth by the myomectomy route during 12, 24, and 36 months of follow-up (2015-2019). We also conducted 12-month interval-based analyses that used logistic regression to estimate odds ratios and 95% CIs for associations of interest. In all analyses, we used propensity score weighting to adjust for differences across surgical routes. RESULT(S): Among 1,095 women who underwent myomectomy (abdominal = 388, hysteroscopic = 273, and laparoscopic = 434), 202 reported pregnancy and 91 reported live birth during 36 months of follow-up. There was little difference in the 12-month probability of pregnancy or live birth by route of myomectomy overall or among women intending pregnancy. In interval-based analyses, adjusted ORs for pregnancy were 1.28 (95% CI, 0.76-2.14) for hysteroscopic myomectomy and 1.19 (95% CI, 0.76-1.85) for laparoscopic myomectomy compared with abdominal myomectomy. Among women intending pregnancy, adjusted ORs were 1.27 (95% CI, 0.72-2.23) for hysteroscopic myomectomy and 1.26 (95% CI, 0.77-2.04) for laparoscopic myomectomy compared with abdominal myomectomy. Associations were slightly stronger but less precise for live birth. CONCLUSION(S): The probability of conception or live birth did not differ appreciably by the myomectomy route among women observed for 36 months postoperatively. CLINICAL TRIALS REGISTRATION NUMBER: (NCT02260752, clinicaltrials.gov).
引用
- Wise LA, Thomas L, Anderson S, et al. Route of myomectomy and fertility: a prospective cohort study. Fertil Steril. 2022. PMID: 35216832. doi:10.1016/j.fertnstert.2022.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。